Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/999
Title: Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance.
Epworth Authors: Myers, Ken
Clough, Anthony
Other Authors: Jolley, D.
Kirwan, J.
Keywords: Ultrasound-guided Sclerotherapy
Superficial Chronic Venous Ddisease
Varicose Veins
Saphenous Vein
Saphenous Reflux
Sclerotherapy
Chronic Disease
Kaplan-Meier Estimate
Life Tables
Age Distribution
Patient Selection
Proportional Hazards Models
Prospective Studies
Recurrence
Risk Factors
Follow-Up Studies
Diagnostic Imaging
Adverse Effects
Time Factors
Treatment Outcome
Ultrasonography
Interventional
Venous Thrombosis
Etiology
Melbourne Vascular Ultrasound, Epworth Hospital, Victoria, Australia
UroRenal, Vascular Clinical Institute, Epworth HealthCare, Victoria, Australia
Issue Date: Jan-2007
Publisher: European Society for Vascular Surgery, Elsevier
Citation: 2007 Jan;33(1):116-21.
Abstract: OBJECTIVE: To estimate medium-term success after a technique for ultrasound-guided sclerotherapy for superficial chronic venous disease. DESIGN: A prospective study in a single unit with ultrasound surveillance after treatment. MATERIALS: Results after 1189 treatment sessions for 807 venous saphenous veins and related tributaries or non-saphenous tributaries in 489 patients. METHODS: Univariate life table analysis determined primary and secondary success rates. Multivariate Cox regression analysis detected covariates that affected outcome. RESULTS: Primary and secondary success rates at 36 months for all veins were 52.4% (95%CI 46-58%) and 76.8% (95%CI 71-82%). Cox regression analysis for primary success for all veins showed significantly worse results for saphenous veins compared to tributaries (HR 3.72 - 95%CI 1.9 to 7.3). Cox regression for all saphenous veins showed independently worse results for patients less than 40 years age (HR 2.16 - 95%CI 1.27-3.66), small compared to great saphenous veins (HR 1.58 - 95%CI 1.11-2.24), veins greater than 6mm diameter compared to smaller veins (HR 2.22 - 95%CI 1.40-3.50), liquid compared to foam sclerotherapy (HR 2.20 - 95%CI 1.28-3.78), lower volumes of sclerosant compared to volumes greater than 12 ml (HR 0.51 - 95%CI 0.33-0.81) and highly diluted compared to concentrated sclerosant (HR 2.05 - 95%CI 1.21-3.46) with worse results using highly diluted or undiluted 3% sclerosant compared to a 1.5% concentration. There were no significant differences for primary success for saphenous veins for date of procedure, sex, side, primary or recurrent varicose veins, or commercial type of sclerosant. CONCLUSIONS: Ultrasound-guided sclerotherapy gives satisfactory results if it is accepted that treatment may need to be repeated to achieve secondary success. Results provide a basis for further research to explore factors that might affect outcome. Younger patients with larger diameter saphenous veins may warrant alternative forms of treatment, particularly for small saphenous reflux.
URI: http://hdl.handle.net/11434/999
DOI: 10.1016/j.ejvs.2006.09.005
URL: http://www.sciencedirect.com/science/article/pii/S1078588406005028
PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/17067832
ISSN: 1078-5884
Journal Title: European Journal of Vascular and Endovascular Surgery
Type: Journal Article
Type of Clinical Study or Trial: Prospective Cohort Study
Appears in Collections:Diagnostic Services
UroRenal, Vascular

Files in This Item:
File Description SizeFormat 
outcome of ultrasound-guided sclerotherapy.pdf182 kBAdobe PDFView/Open


Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.